FOCUS-2
"FOCUS-2" is a figurative mark owned by Axsome Therapeutics, Inc., filed at the UKIPO on September 1, 2026. It is filed and waiting for examination and covers class 5 (Pharmaceuticals).
- Status
- Filed
- Since September 1, 2026
- Filed
- September 1, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- UK00004438977
- Registration no.
- UK00004438977
- Office
- UKIPO
- Intellectual Property Office
- Mark type
- Figurative mark
- 1 class
Who owns FOCUS-2
The owner and representative on file with the office.
Owner
Axsome Therapeutics, Inc.
United States
Representative
Keltie LLP
Keltie LLP
What the mark covers
The products and services FOCUS-2 is filed for, grouped by Nice class.
Medicated and pharmaceutical preparations for use in the treatment of ADHD; prescription medicines for the treatment of ADHD.
About FOCUS-2
Who owns the trademark "FOCUS-2"?
The UKIPO trademark "FOCUS-2" (application UK00004438977) is owned by Axsome Therapeutics, Inc.
What is the status of "FOCUS-2"?
Its status at the UKIPO is: filed.
Get this data via the API
Everything on this page comes from the Signa API. Pull FOCUS-2 and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a0602e-1493-75c5-9da2-4fedcf1907ea
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a0602e-1493-75c5-9da2-4fedcf1907ea",
"object": "trademark",
"mark_text": "FOCUS-2",
"status": {
"primary": "pending",
"stage": "filed"
},
"office_code": "GB",
"application_number": "UK00004438977",
"filing_date": "2026-09-01",
"nice_classes": [
5
],
"owners": [
{
"name": "Axsome Therapeutics, Inc.",
"entity_id": null
}
]
}